BBVA


EPS upgrade on lower loan impairments

18/11/20 -"The increase in the target price is fully attributable to our decision to forecast the resumption of a dividend payment next year."

Pages
55
Language
English
Published on
18/11/20
You may also be interested by these reports :
02/07/25
The market rumours were correct. SAB accepted the sale of its UK unit, TSB, to SAN. If completed, the acquisition will not materially improve SAN ...

01/07/25
As expected, BBVA announced its decision to maintain its offer on SAB, potentially responding to press articles mentioning confirmed interest in TSB. ...

18/06/25
Pbb has decided to completely discontinue pbb’s US business and to sell, securitise or respectively run-down the US portfolio. Pbb has said that, in ...

18/06/25
We have updated the share count following the successive buybacks performed by the group over the past months which have notably resulted in the full ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO